Approval · Notice of Compliance 34592 · 2024
NAT-ZOLMITRIPTAN: Notice of Compliance 34592
Issued December 20, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34592
- Date
- December 20, 2024
- Company
- Natco Pharma (Canada) IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAT-ZOLMITRIPTAN | Not yet assigned | — |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB